ES Response to HHS Rebate Proposal to Lower Drug Costs
April 8, 2019 | The Endocrine Society responded to a proposal by HHS to pass rebates onto patients as one way to lower out-of-pocket drug costs. The Society raised a number of questions about how this change will impact patients and underscored the importance of ensuring consumer protections.
House Appropriations Testimony for FY2020
April 2, 2019 | The Endocrine Society asks that the NIH receive total funding of least $41.6 billion for fiscal year (FY) 2020, the Centers for Disease Control and Prevention (CDC) receive funding of at least $7.8 billion; and that the Title X program be funded at $400 million.
Coalition for Health Funding 302b Letter
April 1, 2019 | The Endocrine Society joined 550 organizations calling on lawmakers to raise the caps on non-defense discretionary spending in FY 2020 and to deliver a strong funding allocation for the Departments of Labor, Health and Human Services, and Education and Related Agencies spending bill in FY 2020.
DAA Coalition Comments on Telehealth
March 27, 2019 | The Endocrine Society and the Diabetes Advocacy Alliance provided comments to the Congressional Telehealth Caucus in response for their request for information on how to use telehealth to tackle the diabetes epidemic.
Representing the Endocrine Society, our members strive to influence public policy related to research and clinical endocrinology issues by testifying before the United States Congress, Federal agencies, and other legislative and deliberative bodies.